|
Market Closed -
Nasdaq Stockholm
21:00:00 18/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 203.50 SEK | +0.49% |
|
+0.49% | +29.45% |
Company Valuation: CellaVision AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,757 | 5,462 | 5,057 | 5,188 | 3,749 | 4,830 | - | - |
| Change | - | -29.58% | -7.42% | 2.59% | -27.72% | 28.82% | - | - |
| Enterprise Value (EV) 1 | 7,763 | 5,456 | 5,000 | 5,065 | 3,587 | 4,631 | 4,578 | 4,507 |
| Change | - | -29.71% | -8.37% | 1.31% | -29.18% | 29.11% | -1.15% | -1.53% |
| P/E | 61.9x | 46.2x | 38.8x | 36.9x | 24.5x | 33.4x | 25.9x | 22.9x |
| PBR | 14.3x | 8.51x | 7.06x | 6.36x | 4.22x | 4.94x | 4.44x | 3.97x |
| PEG | - | -8.36x | 3.8x | 4.58x | 2.78x | -5.97x | 0.9x | 1.8x |
| Capitalization / Revenue | 13.7x | 8.54x | 7.47x | 7.17x | 4.94x | 6.13x | 5.46x | 5.01x |
| EV / Revenue | 13.7x | 8.53x | 7.38x | 7x | 4.73x | 5.88x | 5.18x | 4.68x |
| EV / EBITDA | 39.6x | 27.5x | 24.2x | 23.2x | 14.9x | 19.3x | 15.5x | 13.8x |
| EV / EBIT | 47.7x | 34.5x | 29.9x | 28.5x | 17.8x | 25.3x | 19.2x | 16.8x |
| EV / FCF | 68x | 81.1x | 45.1x | 41.4x | 31.4x | 39.2x | 34.4x | 29.1x |
| FCF Yield | 1.47% | 1.23% | 2.22% | 2.42% | 3.19% | 2.55% | 2.9% | 3.44% |
| Dividend per Share 2 | 2 | 2 | 2.25 | 2.5 | 2.75 | 2.75 | 3.203 | 3.477 |
| Rate of return | 0.62% | 0.87% | 1.06% | 1.15% | 1.75% | 1.36% | 1.58% | 1.72% |
| EPS 2 | 5.25 | 4.96 | 5.46 | 5.9 | 6.42 | 6.061 | 7.817 | 8.834 |
| Distribution rate | 38.1% | 40.3% | 41.2% | 42.4% | 42.8% | 45.4% | 41% | 39.4% |
| Net sales 1 | 565.6 | 639.3 | 677.3 | 723.2 | 759 | 787.6 | 883.9 | 963.4 |
| EBITDA 1 | 196.2 | 198.4 | 206.8 | 218.7 | 241.4 | 239.9 | 295.4 | 327.3 |
| EBIT 1 | 162.7 | 158.3 | 167.1 | 177.7 | 202.1 | 182.8 | 238 | 269 |
| Net income 1 | 125.3 | 118.3 | 130.3 | 140.7 | 153.1 | 144.7 | 186.6 | 210.6 |
| Net Debt 1 | 6.368 | -5.558 | -56.94 | -122.6 | -162.6 | -198.8 | -252.3 | -322.5 |
| Reference price 2 | 325.20 | 229.00 | 212.00 | 217.50 | 157.20 | 202.50 | 202.50 | 202.50 |
| Nbr of stocks (in thousands) | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | - | - |
| Announcement Date | 04/02/22 | 08/02/23 | 07/02/24 | 06/02/25 | 05/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 33.41x | 5.88x | 19.3x | 1.36% | 478M | ||
| 35.17x | 6x | 22.94x | 0.27% | 254B | ||
| 35.89x | 6.83x | 21.39x | 0.64% | 159B | ||
| 49.79x | 12.01x | 25.77x | -.--% | 149B | ||
| 17.57x | 3.47x | 11.32x | -.--% | 62.37B | ||
| 45.46x | 8.39x | 26.46x | -.--% | 60.62B | ||
| 21.21x | 2.53x | 12.75x | 2.38% | 53.05B | ||
| 34.34x | 6.65x | 22.5x | 0.6% | 48.55B | ||
| 44.15x | 10.74x | 23.67x | -.--% | 46.7B | ||
| 130.24x | 7.44x | 22.61x | -.--% | 44.21B | ||
| Average | 44.72x | 6.99x | 20.87x | 0.52% | 88B | |
| Weighted average by Cap. | 41.61x | 7.31x | 21.94x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CEVI Stock
- Valuation CellaVision AB
Select your edition
All financial news and data tailored to specific country editions
















